Fedwire adopts ISO 20022, boosts XRP, XLM, ADA and ALGO
The U.S. Federal Reserve has officially adopted ISO 20022 for its Fedwire Funds Service, with several cryptocurrencies including XRP, Stellar, Algorand and Cardano, already compliant with the new international messaging standard.
Fedwire, the U.S. central bank’s real-time gross settlement system, is adopting the standard to enhance cross-border payments. This move comes as the global financial ecosystem sees increased adoption of modern payment technologies that prioritize speed, security, and, crucially, interoperability.
XRP, XLM, ALGO are ISO 20022 compliant
ISO 20022, already in operation across multiple countries, will now apply to all financial institutions using Fedwire. Banks and service providers will begin transitioning to a unified global payments framework and communication language. The standard takes effect for Fedwire on July 14, 2025.
As top banks look to tap into blockchain projects that have since become ISO 20022 stand a better chance of traction. Speed and programmable settlements are a major benefit that blockchain offers.
Ripple’s XRP ( XRP ), Stellar ( XLM ), Cardano ( ADA ) and Algorand ( ALGO ) are among the projects meeting this standard. Others are Quant and Hedera . XRP remains the most prominent cross-border crypto asset, bolstered by Ripple’s On-Demand Liquidity platform and a wide array of banking partnerships.
These tokens have seen notable price spikes over the past 24 hours, with XRP, XLM, and ADA reaching key technical levels.
ALGO price- bulls hit 4-month high
Algorand, a layer-1 proof-of-stake blockchain, is among the tokens surging in response to the Fedwire news.
The ALGO token’s price has climbed 10% in the past 24 hours, extending weekly gains to over 61% as it breaks above $0.30. The rally comes alongside a 95% surge in daily trading volume, now above $688 million.
Meanwhile, data from Coinglass shows Algorand derivatives volume has increased by more than 112% to $919 million. Open interest has also climbed, rising 24% to over $153 million, metrics that point to growing bullish sentiment around ALGO’s short-term outlook.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

